Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
AAIPharma Services Corp./Cambridge Major Laboratories, Inc. (AAI/CML), a provider of contract manufacturing and development services for the pharmaceutical and biotechnology industries, has expanded its IDBS E-WorkBook platform across analytical ...
read more
Thursday, February 04, 2016
AAIPharma Services Corp./Cambridge Major Laboratories, Inc., a provider of custom manufacturing and development services for the pharmaceutical and biotechnology industries, has announced an integrated service offering for solid state chemistry and ...
read more
Wednesday, September 30, 2015
AAIPharma Services/Cambridge Major Laboratories has recently expanded its service capabilities to offer two sites as options for placement of Disinfectant Effectiveness/ Disinfectant Qualification (DE/DQ) studies.
read more
Friday, February 12, 2016
AAIPharma Services Corp./Cambridge Major Laboratories, Inc. (AAI/CML), a leading provider of custom manufacturing and development services for the pharmaceutical and biotechnology industries, has announced expanded sterile fill-finish capabilities ...
read more
Thursday, February 18, 2016
AAIPharma Services Corp./Cambridge Major Laboratories a provider of custom manufacturing and development services for the pharmaceutical and biotechnology industries, has announced the planned investment of at least $10.7 Million to relocate its St. ...
read more
Belgium-based AARDEX Group, the world leader in medication adherence solutions, announced a strategic partnership with AdhereTech, an innovative company that improves the patient experience with real-time technology and Smart devices for optimal ...
read more
Adherence specialists AARDEX Group are proud to announce its partnership with other industry leaders on DiMe’s new Extending the Verification, Analytical Validation, and Clinical Validation (V3+) Framework project.
read more
Belgium-based AARDEX® Group, the leader in measuring and managing medication adherence in clinical trials today announced a strategic partnership with etectRx, Inc. This new collaboration combines etectRx’s ingestible event marker, the ID-Cap™ System...
read more
Wednesday, April 28, 2021
AavantiBio and Catalent have announced a partnership to support the development and manufacturing of AavantiBio’s gene therapies.
read more
Monday, November 02, 2020
AB2 Bio and WuXi Biologics have entered into a collaboration to set-up and accelerate commercial-scale manufacturing of Tadekinig alfa, AB2 Bio’s novel recombinant IL-18 binding protein.
read more
Abarca has signed a value-based reimbursement contract with Biogen for select products in Biogen's leading multiple sclerosis portfolio.
read more
Abbott announced the FDA has issued Emergency Use Authorization for the company's molecular test for novel coronavirus.
read more
Friday, November 09, 2018
AbbVie announced patent license agreements with Momenta over its proposed biosimilar adalimumab product.
read more
Friday, November 30, 2018
AbbVie announced patent license agreements with Pfizer over its proposed biosimilar adalimumab product.
read more
AbbVie (NYSE: ABBV) has named Michael Severino, M.D. its new Executive Vice President, Research and Development (R&D) and Chief Scientific Officer. Dr. Severino's track record of innovation within the biotech industry aligns with AbbVie's vision as ...
read more